• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acetanilides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides Acetanilides

Research Brief on N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide (CAS: 16503-61-0): Recent Advances and Applications

N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide (CAS: 16503-61-0) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its bromo, methyl, and nitro functional groups, serves as a critical intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential applications in drug discovery, particularly in the development of novel antimicrobial and anticancer agents. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its synthesis, mechanistic insights, and therapeutic potential.

Recent literature has emphasized the role of N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide as a versatile building block in organic synthesis. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of indole derivatives, which exhibit potent inhibitory effects against bacterial pathogens. The study employed a multi-step reaction sequence, starting with the bromination of 4-methyl-5-nitroaniline, followed by acetylation to yield the target compound. The resulting derivatives showed remarkable activity against methicillin-resistant Staphylococcus aureus (MRSA), underscoring the compound's potential in addressing antibiotic resistance.

In addition to its antimicrobial properties, N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide has been investigated for its anticancer potential. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported the compound's role in the synthesis of quinoline-based inhibitors targeting protein kinases involved in cancer cell proliferation. The researchers utilized computational docking studies to predict the binding affinity of the synthesized compounds, followed by in vitro assays to validate their efficacy. The results indicated that derivatives of N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide exhibited selective inhibition of cancer cell lines, with minimal toxicity to normal cells.

Mechanistic studies have further elucidated the compound's mode of action. For instance, a 2023 paper in Chemical Biology & Drug Design explored the compound's interaction with bacterial DNA gyrase, a key enzyme in DNA replication. The study revealed that the bromo and nitro substituents play a critical role in stabilizing the enzyme-inhibitor complex, thereby disrupting bacterial DNA synthesis. These findings provide a molecular basis for the compound's antimicrobial activity and offer insights for the design of next-generation antibiotics.

Despite its promising applications, challenges remain in the large-scale synthesis and optimization of N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide. A 2021 review in Organic Process Research & Development highlighted the need for greener synthetic routes to minimize environmental impact. Recent advances in catalytic methods, such as palladium-catalyzed cross-coupling reactions, have shown potential in improving the efficiency and sustainability of the synthesis process. These developments are expected to facilitate the compound's broader adoption in pharmaceutical research.

In conclusion, N-(2-Bromo-4-methyl-5-nitrophenyl)acetamide (CAS: 16503-61-0) represents a valuable tool in the development of novel therapeutic agents. Its versatility as a synthetic intermediate, coupled with its demonstrated biological activities, positions it as a compound of interest for future research. Ongoing studies are likely to uncover additional applications, particularly in the context of drug resistance and targeted therapy. Researchers are encouraged to explore its potential further, leveraging advances in synthetic chemistry and computational modeling to optimize its efficacy and safety.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)